Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dexmedetomidine effect on propofol ED50 for upper gastrointestinal endoscope insertion
ChiCTR2200055952Phase 4Completed
- Sponsor
- Beijing Friendship Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Propofol alone with Dexmedetomidine + propofol (2 arms). Primary endpoint: Median effective dose (ED50) of propofol for successful upper gastrointestinal endoscope insertion. Started Jan 2022; status: completed.
02
Drugs
propofoldexmedetomidine
Beyond the preview
Go deeper on ChiCTR2200055952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055952.